comparemela.com

Latest Breaking News On - Carvey leung - Page 1 : comparemela.com

Oncolytics Biotech Inc (NASDAQ:ONCY) Q4 2023 Earnings Call Transcript

Operator: Good afternoon, and welcome to Oncolytics Biotech s Fourth Quarter and Full Year 2023 Conference Call. All participants are now in a listen-only mode.

Breast Cancer-Focused Atossa Therapeutics Can Possibly Change Treatment Paradigm: Analyst - Atossa Therapeutics (NASDAQ:ATOS)

Cantor Fitzgerald has initiated coverage of Atossa Therapeutics Inc (NASDAQ: ATOS) with an Overweight rating and 

Mesoblast s Mixed Bag: Lower Revenues but a Promising Path Forward - Mesoblast (NASDAQ:MESO)

Wednesday, Mesoblast Ltd (NASDAQ: MESO) FY23 results, with revenues of $7.5 million for FY2023, compared to $10.2 million in FY2022, 

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.